Introduction {#sec1-1}
============

The word *Tamaka Shvasa* is derived from the word *Tama*, the meaning of "*Tama*" is oppression of chest\[[@ref1]\] which is similar to bronchoconstriction felt by the patients of asthma due to sensation arising from resistive airways. Asthma is a chronic inflammatory disorder of airway hyper responsiveness that leads to recurrent episodes of wheezing, breathlessness, chest tightness, and coughing, particularly at night or early in the morning. The prevalence of self-reported asthma was 1.8% among men and 1.9% among women.\[[@ref2]\] Females, high body mass index, low body mass index, advancing age, residence in urban area, lower socioeconomic status, rapid industrialization, increased population, increase in air pollution, and all forms of tobacco smoking increase the risk of asthma.\[[@ref3]\]

Faulty food habits lead to *Agnimandya* and responsible for *Annavaha Srotodushti* which is the basic cause for the initiation of *Samprapti*, as *Mulasthana* of *Tamaka Shvasa* is *Pittasthana*. Modern science also accepts the role of diet in bronchial asthma as diets low in antioxidants and some foods, such as shellfish and nuts, may induce anaphylactic reaction are associated with an increased risk of asthma.\[[@ref4]\] *Viharaja Nidanas* are mainly *Vata Prakopaka* and *Pranavaha Srotodushtikara*. *Raja*, *Dhuma* etc. are indicating toward the allergens; seasonal changes also can be considered as aggravating factors in the manifestation of disease.

The disease is originated from *Pittasthana* and situated in *Kapha Sthana* characterized by dominant features of vitiated *Kapha* along with obstruction to movement of *Vata* causing *Vata Prakopa* and breathlessness.\[[@ref5]\] Considering the above fact in the pathogenesis of *Tamaka Shvasa*, it may be assumed that *Vamana Karma* is most suitable therapeutic procedure for the disease and *Ikshvaku* has anti-allergic, anti-inflammatory, emetic, and *Rasayana* properties. Therefore, to evaluate its *Vamaka* effect on bronchial asthma, the present study was carried out.

Materials and Methods {#sec1-2}
=====================

The study was conducted on the patients who reported in the outpatient and inpatient department of Panchakarma, IPGT and RA, GAU, Jamnagar, for the treatment of bronchial asthma.

A total of 15 patients of *Tamaka Shvasa* (bronchial asthma) of both the sex having age in between 16 and 55 years with disease chronicity up to 10 years were selected for the study.

The study design was approved by the Institutional Ethics Committee vide its letter no. PGT/A/Ethics/201112/2687.Dt. 05/09/2011 and was also registered in clinical trial \[CTRI/2014/01/004330\] registry of India. Written informed consent was obtained from each patient before including them in the trial.

Before conducting clinical trial for quality control of *Ikshvaku* (*Lagenaria vulgaris* \[Manila\] Standley) fruits were collected from the local farms of Chandrapur district, Maharashtra in December--January. The fresh and semi-ripped fruits were cut into small pieces. The pulp obtained from fruits were shade dried and made into the coarse powder and later its pharmacognostical, physicochemical, and phytochemical evaluation was carried out at IPGT and RA, GAU, Jamnagar \[Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}\].
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Physicochemical parameters of *Ikshvaku Churna*
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Qualitative tests
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Inclusion criteria {#sec2-1}
------------------

Patients having classical features of *Tamaka Shvasa* (bronchial asthma) mainly cough, breathlessness, and rhonchi were selected for the studyRaised erythrocyte sedimentation rate (ESR) and absolute eosinophil count (AEC)Patients having peak expiratory flow rate (50--200 L/min)Patients having force expiratory volume (50%--80%) as that of predicted.

Exclusion criteria {#sec2-2}
------------------

Patients suffering from pulmonary tuberculosis, carcinoma of lung, lung fibrosis, lung abscess, bronchiectasis, cor pulmonale, ischemic heart disease, any other systemic illness were excluded from present study.

Posology {#sec2-3}
--------

All the registered patients who met inclusion criteria and gave consent for the *Vamana* were administered *Trikatu Churna*\[[@ref6]\] for the first 3 days for *Deepana* and *Pachana*\[[@ref7]\] in the dose of 3 g thrice a day with lukewarm water after meal. On the 4^th^ day, after assessing the status of the patients, nonmedicated ghee in the dose of 30 ml was given in the early morning on an empty stomach with lukewarm water. The patients were observed for *Sneha Jeerna Lakshana* and accordingly for the next 5--7 days; the dose of ghee was given in increased pattern till the patients achieved proper *Snehana* features (*Samyaka Snigdha Lakshana)*.\[[@ref8]\] After completion of *Snehapana*, whole-body massage and fomentation with *Bala Taila* and *Vashpa Swedana* was done for 1 day at morning and evening according to strength of the patient. A night before *Vamana*, the patients were given *Kapha Bahula* diet such as curd, milk, and sugarcane juice. On the day of planned *Vamana* procedure in the morning after *Abhyanga* and *Bashpa Swedana*, patients were given milk to drink up to their satisfaction. Thereafter, *Vamana* with *Ikshvaku Ksheera Yoga* was given.

Method of preparation of *Ikshvaku Ksheera Yoga* {#sec2-4}
------------------------------------------------

For the preparation of *Ikshvaku Ksheera Yoga* 2 g (each) coarse powder of *Vacha*, *Pippali*, and *Saindhava lavana* was added in 4 g of *Ikshvaku Churna*. It was then mixed 20 g with honey and 60 ml milk to make the formulation (*Yoga)* more palatable.\[[@ref9]\]

Thereafter, according to the type of *Shuddhi*, at the end of *Vamana* procedure, 3, 5, and 7 days, dietary regimen was advised which included *Peya*, *Vilepi*, *Akrita Yusha*, and *Krita Yusha* in a sequential pattern.\[[@ref10]\]

After completion of *Vamana*, patients were asked to report after 15 days to record the details regarding the status.

Criteria for assessment {#sec2-5}
-----------------------

Subjective parameters presented by the patients were given score and were assessed before and after performing *Vamana Karma*.

Gradation for Subjective parameters:

ShvasakashtataThe MRC breathlessness scale was adopted for *Shvasa Kashtata*.Not trouble with breathlessness except on strenuous exercise-1Short of breaths when hurrying on the level or walking up a slight hill-2Walks slower than most people on the level, stops after a mile or so or stops after 15 min walking at own pace-3Stops for breath after walking about 100 yards or after a few minute on level ground-4Too breathlessness to leave the house or breathlessness when undressing-5.*Kasa* (cough) duration/severityNo cough- 0Occ. cough-11--2 time/day- 22--5 time/day- 3Throughout day- 4Throughout day and night- 5RhonchiNo rhonchi- 0Localized (inspiration/expiration)- 1Scattered unilateral (inspiration/expiration)- 2Scattered bilateral (inspiration/expiration)- 3Generalized rhonchi (inspiration/expiration)- 4High pitched unilateral (inspiration/expiration)- 5High pitched bilateral (inspiration/expiration)- 6

Objective parameters {#sec2-6}
--------------------

Improvement in lung function tests mainly peak expiratory flow rate and forced expiratory volume (FEV) was observed. Changes in hematological parameters mainly ESR and AEC were also considered for assessment, and they were assessed in comparison to the baseline score.

Statistical analysis {#sec2-7}
--------------------

General data were subjected to suitable statistical analysis such as descriptive statistics for demographic data, Wilcoxon signed-rank test for nonparametric paired data and paired *t*-test for quantitative parametric paired data. After preparing the master chart of all the required data in Microsoft Excel worksheet, statistical calculations were made with the help of SigmaStat 3.5 software, San Jose, California and InStat 3 software, La Jolla, USA. The results were interpreted as significant (*P* \< 0.05), highly significant (*P* \< 0.01), and insignificant (*P* \> 0.05).

Observations {#sec2-8}
------------

A total of 15 patients have registered in the study, and out of them, 13 patients completed the treatment. Two patients dropped out due to migration. The demographic data show that 73.34% patients were females, 80% belonged to age group of 26--45 years, 66.67% patients were homemakers, and 80% were laborers. Regarding *Prakriti*, 53.33% were of *Kapha-Vata* dominant *Prakriti*. *Madhyama Koshtha* was found in 46.67% of patients followed by 33.33% patients having *Mridu Koshtha*.

Disease chronicity of asthma up to 10 years was found in 33.33% of patients, positive family history of asthma was found in 40% of patients and history of frequent cold was found in 60% of patients while rhinitis in 53.33% of patients. Frequent use of inhalers (beta-agonists) was seen in 73.33% of patients followed by steroids in 46.67% of patients. Ingestion of *Amla Madhura Rasa* dominant *Aahara* was noticed by 66.67% of patients followed by 73.33% of patients taking *Snigdha Guna* dominant. Diet ingestion of curd (*Dadhi Sevana)* was observed in 66.67% of patients while fermented food was taken by 60% of patients; irregular times of food was noted in 60% of patients and *Viruddhahara* was noted in 80% of patients.

Early morning breathlessness was observed in most of the patients, followed by dry cough and productive cough in 40% of patients. Rhonchi was observed in 86.67% of patients and crepitations in 73.33% of patients. In 66.67% of patients, dust, pollens, and day sleep was observed as aggravating factors and extreme cold in 80% of patients. Relief in breathlessness after sitting position was observed in 53.33% of patients.

Observations of *Vamana Karma* {#sec2-9}
------------------------------

Time of induction of first *Vega* during *Vamana Karma* is 28.60 min (average); it shows that *Ikshvaku Ksheer Yoga* takes more time for induction of first *Vega*. After giving *Vamana Yoga*, self-induced *Vega* were observed in 66.67% of patients and projectile *Vega* were observed in 46.66% of patients while *Pittanta Vega* were observed in 73.33% of patients. Average number of *Vega* were 5.93. Average number of *Upavega* were 7.06, indicating that the patients have *Madhyama* to *Pravara Shuddhi* and no complications were observed during *Vamana* \[[Table 3](#T3){ref-type="table"}\].

###### 

*Vamana Vega* observation
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Results {#sec1-3}
=======

Effect of therapy on subjective parameters {#sec2-10}
------------------------------------------

*Vamana Karma* with *Ikshvaku Ksheera Yoga* provided statistically highly significant (*P* \< 0.001) result in breathlessness (79.98%), reduction in frequency of *Shvasakashtata* (69.80%), reduction in number of emergency medicine taken (91.16%), *Kapha Shthivana* (expectoration) (57.7%), *Kasa* (cough) (79.98%), *Ghurghurakam* (wheezing) (85.04%), *Kanthodhvansam* (throat irritation) (83.32%), relief in rhonchi (75.84%) and crepitations (83.98%) \[[Table 4](#T4){ref-type="table"}\].

###### 

Effect of *Vamana* on cardinal symptoms
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Effect of therapy on objective parameters {#sec2-11}
-----------------------------------------

After *Vamana* with *Ikshvaku Ksheera Yoga*, there is increase in hemoglobin% and reduction in ESR and AEC. All these changes reported were statistically insignificant (*P* \> 0.05).

In lung function test, peak expiratory flow rate was increased by 26.33% which was statistically highly significant (*P* \< 0.001). Increase in FEV by 6.35% was also found statistically significant (*P* \< 0.05) \[[Table 5](#T5){ref-type="table"}\].

###### 

Effect of *Vamana* on investigations (biochemical parameters & Lung function test)
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Assessment of overall effect of the therapy showed that *Vamana Karma* with *Ikshvaku Ksheera Yoga* provided complete relief in 26.15% of patients, marked improvement in 53.85% of patients, moderate improvement in 16.67% of patients while 3.33% patients show mild improvement \[[Figure 1](#F1){ref-type="fig"}\].

![Overall effect of therapy](AYU-38-10-g006){#F1}

Discussion {#sec1-4}
==========

It has been established that in all the patients of asthma, dyspnea is due to mechanical interference in ventilation because of airway obstruction. It affects the rate and pattern of breathing. In 60% of patients, asthma attack was observed in early morning, which may be due to early morning fall in circulating adrenaline and decreased plasma cortisol concentration.\[[@ref11]\] In 86% of patients, wheezing may have resulted from localized or diffuse airway narrowing or obstruction caused by bronchoconstriction, mucosal edema, and tenacious secretions; coughing may be due to airway inflammation and hypersensitivity to the allergens. Fifty-three percent of patients reported relief in sitting position because in sitting position diaphragm is lowered and secretion of airways will not obstruct the airways completely.

Maximum number of patients had habit of *Vishtambhi* (less fiber foods), *Vishama Aahara* (irregular food habits), *Diwasvapna* (day time sleeping) and *Ratrijagarana* (night awaking) which leads to improper digestion, Aama production, and initiates the disease process. In the present study, 53.33% of patients were having *Kapha Vata Prakruti* because these persons are more prone to asthmatic attack due to vitiation of *Kapha* and *Vata* which are main causative factors of disease which occurs instantaneously due to dominant *Dosha*.\[[@ref12]\]

In the present study for *Vamana Karma* instead of using the classical *Madanphala Yoga*, *Ikshvaku Ksheera Yoga* was selected due to its good expectorant, emetic, anti-allergic, anti-inflammatory, and *Rasayana* properties. For *Vamana Karma* the average dose of *Ikshvaku Churna* is 4 g and average dose of total *Vamana Yoga* was 27 g. This indicates that the *Utklesha* of *Dosha* was good and *Ikshvaku Ksheer Yoga* is extremely bitter, expectorant, and potent enough to induce projectile and self-induced *Vegas*, particularly in the patients of *Tamaka Shvasa*, and this may be one of the reasons for using formulation specific to the disease.

In objective parameters, it was found that AEC was reduced by 22.31% as earlier researches showed *Vamana Karma* reduces histamine level in the body.\[[@ref13]\] Peak expiratory flow and FEV1% was increased after *Vamana* because of the removal of occluded mucous and reduced airway obstruction.

Probable mode of action of *Vamana* with *Ikshvaku Ksheera Yoga* {#sec3-2}
----------------------------------------------------------------

*Trikatu Churna* was given as *Deepana--Pachana* before *Abhyantara Snehapana* because its inherent properties such as *Aampachana* and *Agnideepana*. *Aampachana* also helps to reduce *Pichhilata* of morbid matter so that they can be easily dislodged. *Snehapana* increases the fluidity and moistness in the body and makes the body soft and unctuous; it helps in dislodging the harmful substances from the tissues.

Though there is no classical reference to add other *Dravya* except milk in the *Ikshvaku Ksheera Yoga*, it was mixed with *Saindhava*, *Pippali*, and *Madhu* as it works on both *Kapha* and *Vata Dosha* to prevent the *Vata* aggravation and to facilitate easy expulsion of *Kapha*. Due to *Samshodhana* (Radical cure), *Bhedaka* (penetration) and *Kaphanissaraka* properties of *Ikshvaku* vitiated and stagnant, *Kapha* may get expelled out from the system and thus clears the channels of circulation, resulting in movement of *Vayu* without any obstruction and ultimately the patient get relief after removal of vitiated *Kapha*. Hence, *Ikshvaku Ksheera Yoga* seems to be more suitable for *Vamana Karma* in the *Tamaka Shvasa*.

Conclusion {#sec1-5}
==========

The result suggested that *Ikshvaku Ksheera Yoga* is safe, efficacious, and best emetic formulation for bronchial asthma due to its *Samshodhana*, *Bhedaka*, and *Kaphanissaraka* properties. Its clinical efficacy on bronchial asthma also suggested that the *Ikshvaku Ksheera Yoga* is extremely potent emetic drug to induce self, projectile *Vega* which relieves the symptoms of the disease immediately and it also provides prevention by reducing frequency and severity of symptoms of *Tamaka Shvasa* for longer duration. Hence, it can be said that *Ikshvaku Ksheera Yoga* can be used as disease-specific emetic formulation for bronchial asthma and best alternative to routine *Vamaka Yogas* in future.
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